Thus, we started to explore the potential impacts of hSPAR on mTOR activation in breast cancer cells, by investigating downstream consequences of mTOR signaling in MDA-MB-231 cells in the presence of hSPAR. The gene discussed is MTOR; the disease is breast cancer.